42 U.S.C. § 285b–8 — Congenital heart disease
submitted 82 years ago by Pub. L. 111-148 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 164 words · no verdicts yet
The Institute's Director may expand and coordinate research on congenital heart disease, covering its causes, long-term outcomes, diagnosis, treatment, prevention, and barriers to lifelong care. The Director may also coordinate this research across institutions and build research networks. This work must consider how it applies to minority and medically underserved communities.
The Director* of the Institute may expand, intensify, and coordinate research and related activities of the Institute with respect to congenital heart disease, which may include congenital heart disease research with respect to—
causation of congenital heart disease, including genetic causes;
long-term outcomes in individuals with congenital heart disease, including infants, children, teenagers, adults, and elderly individuals;
diagnosis, treatment*, and prevention;
studies using longitudinal data and retrospective analysis to identify effective treatments and outcomes for individuals with congenital heart disease; and
identifying barriers to life-long care for individuals with congenital heart disease.
The Director of the Institute may coordinate research efforts related to congenital heart disease among multiple research institutions and may develop research networks.
In carrying out the activities described in this section, the Director of the Institute shall consider the application of such research and other activities to minority and medically underserved communities.
Source credit: (July 1, 1944, ch. 373, title IV, § 425, as added Pub. L. 111–148, title X, § 10411(b)(2), Mar. 23, 2010, 124 Stat. 989.)
- 1944Enacted · Pub. L. 111-148 · 124 Stat. 989
A history note hasn’t been published yet. The record shows enactment by Pub. L. 111-148 on 1944-07-01.
all 0 arguments · sorted by: best
no arguments yet — make the first case